


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:05:09Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406347" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406347</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>bmcid</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">BMC Infect Dis</journal-id><journal-id journal-id-type="pmc-domain-id">36</journal-id><journal-id journal-id-type="pmc-domain">bmcid</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406347</article-id><article-id pub-id-type="pmcid-ver">PMC12406347.1</article-id><article-id pub-id-type="pmcaid">12406347</article-id><article-id pub-id-type="pmcaiid">12406347</article-id><article-id pub-id-type="pmid">40898101</article-id><article-id pub-id-type="doi">10.1186/s12879-025-11425-0</article-id><article-id pub-id-type="publisher-id">11425</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Diagnostic value of Serum Amyloid A (SAA) in HIV-associated pulmonary infections and its correlation with inflammatory markers</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5405-0383</contrib-id><name name-style="western"><surname>Chen</surname><given-names initials="R">Ruifang</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Ren</surname><given-names initials="S">Shuai</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Tang</surname><given-names initials="H">Haicheng</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wu</surname><given-names initials="Q">Qingguo</given-names></name><address><email>wuqingguo@shaphc.org</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01nnwyz44</institution-id><institution-id institution-id-type="GRID">grid.470110.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1770 0943</institution-id><institution>Department of Respiratory and Critical Care Medicine, </institution><institution>Shanghai Public Health Clinical Center, </institution></institution-wrap>No 2901, Caolang Road, Jinshan District, Shanghai, 201508 China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><issue-id pub-id-type="pmc-issue-id">478176</issue-id><elocation-id>1096</elocation-id><history><date date-type="received"><day>4</day><month>6</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="12879_2025_Article_11425.pdf"/><abstract id="Abs1"><sec><title>Objective</title><p id="Par1">To evaluate the impact of Human Immunodeficiency Virus&#160;(HIV) infection on serum amyloid A (SAA) levels in acute pulmonary infections and assess correlations between SAA and other inflammatory markers in HIV-associated pneumonia.</p></sec><sec><title>Methods</title><p id="Par2">In this retrospective case-control study, 48 HIV-positive patients with pulmonary infections (HIV group) and 55 age-matched HIV-negative controls (control group) were enrolled from Shanghai Public Health Clinical Center (2021.5&#8211;2025.5). Demographic, hospitalization duration and laboratory parameters - including SAA, white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), lactate dehydrogenase (LDH), platelet count (PLT), CD4<sup>+</sup> T cell count, and absolute lymphocyte count(ALC) - were systematically collected from both patient cohorts. For intergroup comparisons, the Mann-Whitney U test was employed, while Spearman&#8217;s rank correlation analysis was conducted to assess biomarker associations within the HIV-positive subgroup.</p></sec><sec><title>Results</title><p id="Par3">Among 103 patients, the HIV group had higher male predominance (83.3% vs. 54.5%, <italic toggle="yes">P</italic>&#8201;=&#8201;0.02) and lower CD4<sup>+</sup> T cell count (215.17 vs. 443.41 cells/&#181;L, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05). SAA (178.39 vs. 122.93&#160;mg/L, <italic toggle="yes">P</italic>&#8201;=&#8201;0.032), CRP (64.27 vs. 37.07&#160;mg/L, <italic toggle="yes">P</italic>&#8201;=&#8201;0.031), LDH (310.65 vs. 235.96 U/L, <italic toggle="yes">P</italic>&#8201;=&#8201;0.024), and hospitalization duration (16.83 vs. 13.05 days, <italic toggle="yes">P</italic>&#8201;=&#8201;0.013) were significantly elevated in HIV patients. SAA correlated positively with CRP (<italic toggle="yes">r</italic>&#8201;=&#8201;0.4807), PCT (<italic toggle="yes">r</italic>&#8201;=&#8201;0.3554), LDH (<italic toggle="yes">r</italic>&#8201;=&#8201;0.3564), and PLT (<italic toggle="yes">r</italic>&#8201;=&#8201;0.3094) (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 for all).</p></sec><sec><title>Conclusions</title><p id="Par4">Patients with HIV-associated pulmonary infections exhibited significantly elevated levels of SAA, CRP, and LDH, along with prolonged hospital stays, compared to non-HIV-infected individuals. These findings suggest that HIV infection amplifies systemic inflammatory responses, potentially contributing to extended hospitalization. The robust correlations between SAA and other biomarkers (including CRP, PCT, LDH, PLT) highlight its potential as a key component in early diagnostic panels for HIV-associated pulmonary infections.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Pulmonary infection</kwd><kwd>HIV</kwd><kwd>Inflammatory markers</kwd><kwd>Serum Amyloid A (SAA)</kwd><kwd>Diagnostic accuracy</kwd></kwd-group><funding-group><award-group><funding-source><institution>The Department-level Project of Shanghai Public Health Clinical Center</institution></funding-source><award-id>KY-GW-2025-23</award-id><award-id>KY-GW-2025-23</award-id><award-id>KY-GW-2025-23</award-id><award-id>KY-GW-2025-23</award-id><principal-award-recipient><name name-style="western"><surname>Chen</surname><given-names>Ruifang</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Shuai</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Haicheng</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Qingguo</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Shanghai Science and Technology Innovation Action Plan</institution></funding-source><award-id>22Y11901000</award-id><award-id>22Y11901000</award-id><award-id>22Y11901000</award-id><award-id>22Y11901000</award-id><principal-award-recipient><name name-style="western"><surname>Chen</surname><given-names>Ruifang</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Shuai</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Haicheng</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Qingguo</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par5">Serum amyloid A (SAA), a sensitive acute-phase reactant, surges within 24&#8211;36&#160;h post-infection or trauma, reflecting underlying inflammation [<xref ref-type="bibr" rid="CR1">1</xref>]. Notably, sustained inflammation or chronic pathological stimulation may result in prolonged elevation of SAA levels.While antiretroviral therapy (ART) has transformed HIV into a chronic condition [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], chronic immune activation and sustained inflammation are central pathological features of HIV infection [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. This chronic inflammatory state not only drives long-term complications in people with HIV, but may also impair their ability to mount effective immune defenses against subsequent lung infections.</p><p id="Par6">Given this context, studying how HIV infection alters acute inflammatory responses in pulmonary infections is clinically crucial. While SAA serves as a sensitive biomarker, its diagnostic role in HIV-associated pulmonary infections and relationship with other inflammatory markers remain unclear. We therefore analyzed clinical data from HIV-positive and HIV-negative patients with pneumonia (2021.5&#8211;2025.5) to: (1) Assess how HIV infection status affects acute-phase SAA levels in pulmonary infection patients; (2) Investigating the correlation between SAA and key inflammatory biomarkers (such as C-reactive protein, procalcitonin, white blood cell count, etc.) in HIV-associated pulmonary infections. This study aims to investigate the correlation between serum amyloid A (SAA) and other inflammatory biomarkers in HIV-positive patients with pulmonary infections. These findings will enhance our understanding of inflammatory patterns in this population and offer new insights for clinical diagnosis and inflammation monitoring.</p></sec><sec id="Sec2"><title>Data and methods</title><sec id="Sec3"><title>General data</title><p id="Par7">This study enrolled 48 HIV-positive patients with pulmonary infections treated at Shanghai Public Health Clinical Center&#8217;s Respiratory Medicine Department (2021.5-2025.5). The cohort comprised 40 males and 8 females, with a mean age of 55.44&#8201;&#177;&#8201;14.91 years. Inclusion criteria: (1) Age &gt;18 years; (2) Confirmed pulmonary infection diagnosis; (3) HIV-positive status verified through standardized testing or prior diagnosis with documented long-term antiviral therapy; (4) Complete inflammatory marker panel (including SAA) available.Exclusion criteria: incomplete data or concurrent extrapulmonary infections.</p></sec><sec id="Sec4"><title>Data collection</title><p id="Par8">We retrospectively analyzed demographic and clinical data from both patient groups, capturing gender, age, smoking status, and key comorbidities (hypertension, diabetes, cardiovascular diseases, and malignancies). Admission laboratory profiles (&#8804;&#8201;24&#160;h) encompassed SAA, C-reactive protein (CRP), procalcitonin (PCT), white blood cell count(WBC), platelet count(PLT), absolute lymphocyte count (ALC), CD4<sup>+</sup> T cell count, and Lactate dehydrogenase (LDH) levels. Clinical management data (oxygen therapy requirements) and outcomes (hospital stay duration) were also recorded.</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par9">Statistical analyses were performed using SPSS 25.0 (IBM Corp). Between-group comparisons employed the Mann-Whitney U test, and Spearman&#8217;s rank correlation assessed relationships among HIV group indicators. A <italic toggle="yes">P</italic>-value less than 0.05 was considered as significant and all reported <italic toggle="yes">P</italic>-values are two-sided.</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Baseline clinical characteristics</title><p id="Par10">The two patient groups showed comparable baseline characteristics, with no significant differences in age, smoking status, oxygen requirement, or comorbidities (<italic toggle="yes">P</italic>&#8201;&gt;&#8201;0.05).However, a significant gender disparity was observed between groups (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05), with male patients predominating in the HIV-associated pneumonia cohort (see Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). This finding supports prior research conclusions [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Clinical characteristics of the patient cohorts</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Items</th><th align="left" colspan="1" rowspan="1">HIV-positive cohort<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;48)</th><th align="left" colspan="1" rowspan="1">HIV-negative cohort<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;55)</th><th align="left" colspan="1" rowspan="1">t/X<sup>2</sup></th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Gender</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">9.755</td><td align="left" colspan="1" rowspan="1"><bold>0.002</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Male</td><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Female</td><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">25</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Age</td><td align="left" colspan="1" rowspan="1">55.44&#8201;&#177;&#8201;14.91</td><td align="left" colspan="1" rowspan="1">61.2&#8201;&#177;&#8201;17.39</td><td align="left" colspan="1" rowspan="1">1.791</td><td align="left" colspan="1" rowspan="1">0.076</td></tr><tr><td align="left" colspan="1" rowspan="1">Smoking</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">3.378</td><td align="left" colspan="1" rowspan="1">0.066</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">33</td><td align="left" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;None</td><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">27</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Comorbidity</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.078</td><td align="left" colspan="1" rowspan="1">0.962</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Hypertension</td><td align="left" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Diabetes</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Tumor</td><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Oxygen therapy</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.723</td><td align="left" colspan="1" rowspan="1">0.395</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">31</td><td align="left" colspan="1" rowspan="1">31</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;None</td><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">24</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 showed a statistically significant difference</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec8"><title>Comparison of immunological and inflammatory profiles</title><p id="Par11">Patients in the HIV-associated pneumonia group exhibited significantly lower CD4<sup>+</sup> T cell count compared to controls (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05). Notably, inflammatory markers including SAA (t&#8201;=&#8201;2.172), CRP (t&#8201;=&#8201;2.193), and LDH (t&#8201;=&#8201;2.284) were all markedly elevated in the HIV group (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05). No significant intergroup differences were observed in WBC, ALC, or PCT levels (<italic toggle="yes">P</italic>&#8201;&gt;&#8201;0.05), (see Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Comparative analysis of laboratory parameters in the patient cohorts</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Laboratory&#160;parameters</th><th align="left" colspan="1" rowspan="1">HIV-positive cohort<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;48)</th><th align="left" colspan="1" rowspan="1">HIV-negative cohort<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;55)</th><th align="left" colspan="1" rowspan="1">t</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">WBC(10^9/L)</td><td align="left" colspan="1" rowspan="1">7.09&#8201;&#177;&#8201;4.10</td><td align="left" colspan="1" rowspan="1">8.46&#8201;&#177;&#8201;3.90</td><td align="left" colspan="1" rowspan="1">1.734</td><td align="left" colspan="1" rowspan="1">0.086</td></tr><tr><td align="left" colspan="1" rowspan="1">PLT(10^9/L)</td><td align="left" colspan="1" rowspan="1">239.75&#8201;&#177;&#8201;99.26</td><td align="left" colspan="1" rowspan="1">225.69&#8201;&#177;&#8201;77.94</td><td align="left" colspan="1" rowspan="1">0.804</td><td align="left" colspan="1" rowspan="1">0.423</td></tr><tr><td align="left" colspan="1" rowspan="1">Lymph#(10^9/L)</td><td align="left" colspan="1" rowspan="1">1.028&#8201;&#177;&#8201;0.67</td><td align="left" colspan="1" rowspan="1">1.123&#8201;&#177;&#8201;0.62</td><td align="left" colspan="1" rowspan="1">0.744</td><td align="left" colspan="1" rowspan="1">0.458</td></tr><tr><td align="left" colspan="1" rowspan="1">CRP(mg/L)</td><td align="left" colspan="1" rowspan="1">64.27&#8201;&#177;&#8201;79.20</td><td align="left" colspan="1" rowspan="1">37.07&#8201;&#177;&#8201;40.07</td><td align="left" colspan="1" rowspan="1">2.193</td><td align="left" colspan="1" rowspan="1"><bold>0.031</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">SAA(mg/L)</td><td align="left" colspan="1" rowspan="1">178.39&#8201;&#177;&#8201;120.38</td><td align="left" colspan="1" rowspan="1">122.93&#8201;&#177;&#8201;125.75</td><td align="left" colspan="1" rowspan="1">2.172</td><td align="left" colspan="1" rowspan="1"><bold>0.032</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">PCT(ng/ml)</td><td align="left" colspan="1" rowspan="1">3.09&#8201;&#177;&#8201;11.91</td><td align="left" colspan="1" rowspan="1">0.44&#8201;&#177;&#8201;1.56</td><td align="left" colspan="1" rowspan="1">1.634</td><td align="left" colspan="1" rowspan="1">0.105</td></tr><tr><td align="left" colspan="1" rowspan="1">CD4<sup>+</sup>T cell count(cell/ul)</td><td align="left" colspan="1" rowspan="1">215.17&#8201;&#177;&#8201;278.48</td><td align="left" colspan="1" rowspan="1">443.41&#8201;&#177;&#8201;327.65</td><td align="left" colspan="1" rowspan="1">3.779</td><td align="left" colspan="1" rowspan="1"><bold>0.000</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">LDH(U/L)</td><td align="left" colspan="1" rowspan="1">310.65&#8201;&#177;&#8201;218.59</td><td align="left" colspan="1" rowspan="1">235.96&#8201;&#177;&#8201;98.22</td><td align="left" colspan="1" rowspan="1">2.284</td><td align="left" colspan="1" rowspan="1"><bold>0.024</bold></td></tr><tr><td align="left" colspan="1" rowspan="1">Hospital stays(Day)</td><td align="left" colspan="1" rowspan="1">16.83&#8201;&#177;&#8201;8.67</td><td align="left" colspan="1" rowspan="1">13.05&#8201;&#177;&#8201;6.54</td><td align="left" colspan="1" rowspan="1">2.516</td><td align="left" colspan="1" rowspan="1"><bold>0.013</bold></td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 showed a statistically significant difference</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Correlation analysis of SAA with inflammatory markers in HIV-associated pneumonia</title><p id="Par12">Within the HIV-associated pneumonia cohort, SAA demonstrated significant positive correlations with CRP(<italic toggle="yes">r</italic>&#8201;=&#8201;0.4807), PCT, (<italic toggle="yes">r</italic>&#8201;=&#8201;0.3554), LDH(<italic toggle="yes">r</italic>&#8201;=&#8201;0.3564), and PLT (<italic toggle="yes">r</italic>&#8201;=&#8201;0.3094)(<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05). However, no significant associations were observed between SAA levels and WBC, CD4<sup>+</sup> T cell count, or ALC (all <italic toggle="yes">P</italic>&#8201;&gt;&#8201;0.05, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Correlation between SAA levels and inflammatory markers/hospitalization duration in HIV patients with pulmonary infections</p></caption><graphic id="d33e691" position="float" orientation="portrait" xlink:href="12879_2025_11425_Fig1_HTML.jpg"/></fig></p><p id="Par13">As shown in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>, Patients in the HIV-associated pneumonia cohort present significantly higher CRP, LDH, and SAA levels than HIV-negative controls. Notably, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref> further demonstrates a strong correlation between SAA and both CRP and LDH in this population. Together, these findings emphasize the clinical value of these biomarkers&#8217; co-elevation, pointing to a heightened inflammatory burden in patients with HIV-associated pneumonia.</p></sec><sec id="Sec10"><title>Comparison of hospitalization duration between groups</title><p id="Par14">Patients with HIV-associated pneumonia exhibited significantly prolonged hospitalization compared to the control group (t&#8201;=&#8201;2.516, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). However, SAA levels showed no significant correlation with hospital stay duration in this cohort (<italic toggle="yes">r</italic>&#8201;=&#8201;0.0803, <italic toggle="yes">P</italic>&#8201;&gt;&#8201;0.05, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).</p></sec></sec><sec id="Sec11"><title>Discussion</title><p id="Par15">The hallmark of HIV infection is progressive CD4<sup>+</sup> T lymphocyte depletion, resulting in persistent immunodeficiency that markedly increases susceptibility to opportunistic infections, particularly pulmonary complications [<xref ref-type="bibr" rid="CR8">8</xref>]. Our findings demonstrate significantly reduced CD4<sup>+</sup> T cell count in HIV-infected patients compared to controls (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05), confirming this immunopathological basis. Notably, even with effective ART, HIV infection sustains chronic immune activation and inflammatory responses involving T cells, B cells, and monocytes, accompanied by elevated pro-inflammatory cytokines including TNF-&#945;, IL-6, and acute-phase proteins such as CRP [<xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR14">14</xref>]. This persistent inflammatory state not only contributes to non-AIDS-related morbidity and mortality [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], but may also fundamentally alter inflammatory responses to acute secondary infections, such as the pulmonary infections central to this investigation.</p><p id="Par16">As a key acute-phase protein, SAA rapidly escalates following inflammatory stimuli and orchestrates pathogen clearance by recruiting monocytes, neutrophils, dendritic cells, and T cells to sites of inflammation [<xref ref-type="bibr" rid="CR15">15</xref>]. In chronic inflammatory states, circulating SAA levels&#8212;though lower than acute-phase peaks&#8212;remain elevated above baseline [<xref ref-type="bibr" rid="CR16">16</xref>]. However, there is limited research on the dynamic changes of SAA in HIV-infected individuals, particularly in cases of concurrent acute infections (e.g.pulmonary infections), and its diagnostic value remains underexplored [<xref ref-type="bibr" rid="CR17">17</xref>]. This study therefore addresses a critical gap by examining how chronic HIV infection modulates SAA responsiveness to acute pulmonary inflammation.</p><p id="Par17">A pivotal observation was the markedly higher acute-phase SAA and CRP levels in HIV-positive patients with lung infections versus non-HIV controls (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05), aligning with Hussbekk et al. [<xref ref-type="bibr" rid="CR18">18</xref>]. We propose two mechanistic explanations: (1) The compounding effects of chronic immune activation: HIV-induced low-grade inflammation may hypersensitize the immune system to secondary lung infections, amplifying acute-phase protein release; (2) Increased pathogen burden: Immunodeficiency likely predisposes HIV patients to heavier or polymicrobial infections, intensifying the acute-phase response. Moreover, this study demonstrated significantly elevated serum LDH levels in HIV-infected patients compared to controls (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05), indicating exacerbated tissue damage during concurrent pulmonary infection. Given the well-documented sensitivity of LDH in HIV-associated Pneumocystis pneumonia (PJP) [<xref ref-type="bibr" rid="CR19">19</xref>], these findings further corroborate that pulmonary infection intensifies histopathological injury in HIV-positive individuals. Together, the data explain the prolonged hospitalization observed in these patients (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05).</p><p id="Par18">In analyzing inflammatory markers, we observed that SAA levels in HIV patients with pulmonary infections showed significant positive correlations with CRP, PCT, LDH, and PLT. This finding holds important clinical implications. As CRP and SAA are among the most sensitive acute-phase proteins, their concentrations are strongly associated during inflammation, with SAA typically exhibiting a more pronounced increase [<xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>]. PCT, driven by endotoxin and cytokines, signals bacterial involvement. LDH serves as a highly sensitive biomarker for tissue injury, reflecting cellular damage with remarkable precision. Beyond its well-known role in hemostasis, emerging evidence highlights PLT as pivotal &#8220;first responders&#8221; in infection immunity. They actively combat pathogens through direct microbicidal action and by orchestrating immune cell-mediated pathogen clearance [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. These linkages position SAA as a integrative biomarker reflecting inflammatory intensity, tissue injury, and immune engagement in HIV-lung coinfection. In clinical practice, this approach offers a more effective predictive tool for early diagnosis of acute infections in patients with prolonged chronic infections. Furthermore, the study revealed no significant correlation between SAA levels in HIV patients with pulmonary infections and either CD4<sup>+</sup> T cell counts or hospitalization duration. This may be attributed to SAA&#8217;s nature as a highly sensitive but short-lived inflammatory marker&#8212;it surges rapidly within 24&#160;h of stimulation and declines swiftly post-acute phase. Consequently, while it detects inflammation effectively, it shows minimal association with long-term clinical outcomes such as hospital stay [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par19">Beyond acute-phase roles, SAA participates in tissue remodeling, atherosclerosis, and cancer metastasis via receptor interactions and metalloproteinase modulation [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR27">27</xref>], suggesting potential implications for HIV-related chronic complications&#8212;a avenue warranting further study.</p><p id="Par20">This study has several potential limitations. First, as a retrospective analysis, it inherently carries a lower level of evidence compared to prospective studies. Second, although all enrolled patients presented with pulmonary infections, the causative pathogens varied substantially, leading to significant microbial heterogeneity. Third, incomplete viral nucleic acid data in the HIV group precluded further analysis of the relationship between infection and viral load. Fourth, the modest sample size (approximately 50 patients) may limit the robustness of the key findings. Despite these limitations, this study represents the first investigation into the role of SAA in HIV patients with acute lung infections, providing a foundation for future research. Addressing these shortcomings will be a priority in subsequent, more in-depth studies.</p></sec><sec id="Sec12"><title>Conclusions</title><p id="Par21">This study establishes that HIV-positive patients with acute lung infections exhibit heightened elevations in SAA, CRP, and LDH versus non-HIV counterparts, indicative of amplified inflammation and tissue damage stemming from chronic immune activation and greater pathogen burden. Crucially, SAA&#8217;s correlations with CRP, PCT, LDH, and PLT underscore its utility as a sensitive, integrative inflammatory marker.</p><p id="Par22">By combining SAA&#8212;with its rapid kinetic response&#8212;and conventional biomarkers (e.g.CRP, PCT), clinicians could improve early diagnosis, severity stratification, and therapeutic monitoring in HIV-associated pneumonias. Future large-scale prospective studies should define SAA&#8217;s dynamic profiles, optimal thresholds, and prognostic value in this vulnerable population.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Ruifang Chen, Shuai Ren and Haicheng Tang contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors gratefully acknowledge the hospital&#8217;s generous support through the hospital-level research project funding.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>R.C. was responsible for data curation, drafting the initial manuscript, editing, and funding acquisition. S. R. and H.T. contributed to conceptualization and methodology development, while Q.W. provided critical revisions to the content. All authors reviewed and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the Department-level Project of Shanghai Public Health Clinical Center (Grant number: No.KY-GW-2025-23) and Shanghai Science and Technology Innovation Action Plan (Grant number: 22Y11901000).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Data is provided within the manuscript.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par23">This research was conducted in compliance with the tenets of the Helsinki Declaration. All stages of the study received ethical approval from the Institutional Review Board of Shanghai Public Health Clinical Center (Approval No.: 2025-S038-03). All patients have provided their informed consent by signing the pan-consent form. Therefore, the Ethics Committee of the Shanghai Public Health Clinical Center granted an exemption from additional informed consent under Article 39 of the &#8216;Measures for the Ethical Review of Biomedical Research Involving Humans.&#8217;</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par24">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par25">The authors declare no competing interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>HIV</term><def><p id="Par26">Human Immunodeficiency Virus</p></def></def-item><def-item><term>SAA</term><def><p id="Par27">Serum Amyloid A</p></def></def-item><def-item><term>ART</term><def><p id="Par28">Antiretroviral therapy</p></def></def-item><def-item><term>CRP</term><def><p id="Par29">C-reactive protein</p></def></def-item><def-item><term>PCT</term><def><p id="Par30">Procalcitonin</p></def></def-item><def-item><term>PLT</term><def><p id="Par31">Platelet</p></def></def-item><def-item><term>WBC</term><def><p id="Par32">White blood cell</p></def></def-item><def-item><term>LDH</term><def><p id="Par33">Lactate dehydrogenase</p></def></def-item><def-item><term>ALC</term><def><p id="Par34">Absolute lymphocyte count</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sack</surname><given-names>GJ</given-names></name></person-group><article-title>Serum amyloid A (SAA) proteins</article-title><source>Subcell Biochem</source><year>2020</year><volume>94</volume><fpage>421</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">32189310</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-030-41769-7_17</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Sack GJ. Serum amyloid A (SAA) proteins. Subcell Biochem. 2020;94:421&#8211;36.<pub-id pub-id-type="pmid">32189310</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-030-41769-7_17</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Cummins NW. Metabolic complications of chronic HIV infection: a narrative review. Pathogens. 2022;11(2).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pathogens11020197</pub-id><pub-id pub-id-type="pmcid">PMC8879342</pub-id><pub-id pub-id-type="pmid">35215140</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Mu W, Patankar V, Kitchen S, Zhen A. Examining chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection. Viruses-Basel. 2024;16(2).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v16020219</pub-id><pub-id pub-id-type="pmcid">PMC10893210</pub-id><pub-id pub-id-type="pmid">38399994</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hileman</surname><given-names>CO</given-names></name><name name-style="western"><surname>Funderburg</surname><given-names>NT</given-names></name></person-group><article-title>Inflammation, immune activation, and antiretroviral therapy in HIV</article-title><source>Curr HIV-AIDS Rep</source><year>2017</year><volume>14</volume><issue>3</issue><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">28434169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11904-017-0356-x</pub-id><pub-id pub-id-type="pmcid">PMC5514315</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Hileman CO, Funderburg NT. Inflammation, immune activation, and antiretroviral therapy in HIV. Curr HIV-AIDS Rep. 2017;14(3):93&#8211;100.<pub-id pub-id-type="pmid">28434169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11904-017-0356-x</pub-id><pub-id pub-id-type="pmcid">PMC5514315</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babu</surname><given-names>H</given-names></name><name name-style="western"><surname>Ambikan</surname><given-names>AT</given-names></name><name name-style="western"><surname>Gabriel</surname><given-names>EE</given-names></name><name name-style="western"><surname>Svensson</surname><given-names>AS</given-names></name><name name-style="western"><surname>Palaniappan</surname><given-names>AN</given-names></name><name name-style="western"><surname>Sundaraj</surname><given-names>V</given-names></name><name name-style="western"><surname>Mupanni</surname><given-names>NR</given-names></name><name name-style="western"><surname>Sperk</surname><given-names>M</given-names></name><name name-style="western"><surname>Cheedarla</surname><given-names>N</given-names></name><name name-style="western"><surname>Sridhar</surname><given-names>R</given-names></name><etal/></person-group><article-title>Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy</article-title><source>Front&#160;Immunol</source><year>2019</year><volume>10</volume><fpage>1965</fpage><pub-id pub-id-type="pmid">31507593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2019.01965</pub-id><pub-id pub-id-type="pmcid">PMC6718454</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Babu H, Ambikan AT, Gabriel EE, Svensson AS, Palaniappan AN, Sundaraj V, Mupanni NR, Sperk M, Cheedarla N, Sridhar R, et al. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Front&#160;Immunol. 2019;10:1965.<pub-id pub-id-type="pmid">31507593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2019.01965</pub-id><pub-id pub-id-type="pmcid">PMC6718454</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Chen M, Dou Z, Wang L, Wu Y, Zhao D, Gan X, Hu R, Ma Y, Zhang F. Gender differences in outcomes of antiretroviral treatment among HIV-infected patients in China: a retrospective cohort study, 2010&#8211;2015. J Acquir Immune Defic Syndr. 2017;76(3):281&#8211;8.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAI.0000000000001500</pub-id><pub-id pub-id-type="pmid">28708809</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>D</given-names></name><name name-style="western"><surname>Zou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Dong</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>T</given-names></name><name name-style="western"><surname>Cui</surname><given-names>W</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name></person-group><article-title>Secular trends in HIV/AIDS mortality in China from 1990 to 2016: gender disparities</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><issue>7</issue><fpage>e219689</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0219689</pub-id><pub-id pub-id-type="pmcid">PMC6638923</pub-id><pub-id pub-id-type="pmid">31318900</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Gao D, Zou Z, Dong B, Zhang W, Chen T, Cui W, Ma Y. Secular trends in HIV/AIDS mortality in China from 1990 to 2016: gender disparities. PLoS ONE. 2019;14(7):e219689.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0219689</pub-id><pub-id pub-id-type="pmcid">PMC6638923</pub-id><pub-id pub-id-type="pmid">31318900</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cribbs</surname><given-names>SK</given-names></name><name name-style="western"><surname>Crothers</surname><given-names>K</given-names></name><name name-style="western"><surname>Morris</surname><given-names>A</given-names></name></person-group><article-title>Pathogenesis of HIV-related lung disease: immunity, infection, and inflammation</article-title><source>Physiol&#160;Rev</source><year>2020</year><volume>100</volume><issue>2</issue><fpage>603</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">31600121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/physrev.00039.2018</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Cribbs SK, Crothers K, Morris A. Pathogenesis of HIV-related lung disease: immunity, infection, and inflammation. Physiol&#160;Rev. 2020;100(2):603&#8211;32.<pub-id pub-id-type="pmid">31600121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/physrev.00039.2018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moir</surname><given-names>S</given-names></name><name name-style="western"><surname>Fauci</surname><given-names>AS</given-names></name></person-group><article-title>B-cell exhaustion in HIV infection: the role of immune activation</article-title><source>Curr opin HIV AIDS</source><year>2014</year><volume>9</volume><issue>5</issue><fpage>472</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">25023621</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/COH.0000000000000092</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Moir S, Fauci AS. B-cell exhaustion in HIV infection: the role of immune activation. Curr opin HIV AIDS. 2014;9(5):472&#8211;7.<pub-id pub-id-type="pmid">25023621</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/COH.0000000000000092</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez-Maza</surname><given-names>O</given-names></name><name name-style="western"><surname>Breen</surname><given-names>EC</given-names></name></person-group><article-title>B-cell activation and lymphoma in patients with HIV</article-title><source>Curr Opin Oncol</source><year>2002</year><volume>14</volume><issue>5</issue><fpage>528</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">12192272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00001622-200209000-00009</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Martinez-Maza O, Breen EC. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol. 2002;14(5):528&#8211;32.<pub-id pub-id-type="pmid">12192272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00001622-200209000-00009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunt</surname><given-names>PW</given-names></name><name name-style="western"><surname>Martin</surname><given-names>JN</given-names></name><name name-style="western"><surname>Sinclair</surname><given-names>E</given-names></name><name name-style="western"><surname>Bredt</surname><given-names>B</given-names></name><name name-style="western"><surname>Hagos</surname><given-names>E</given-names></name><name name-style="western"><surname>Lampiris</surname><given-names>H</given-names></name><name name-style="western"><surname>Deeks</surname><given-names>SG</given-names></name></person-group><article-title>T cell activation is associated with lower CD4&#8201;+&#8201;T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy</article-title><source>J Infect Dis</source><year>2003</year><volume>187</volume><issue>10</issue><fpage>1534</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">12721933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/374786</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG. T cell activation is associated with lower CD4&#8201;+&#8201;T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis. 2003;187(10):1534&#8211;43.<pub-id pub-id-type="pmid">12721933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/374786</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunt</surname><given-names>PW</given-names></name><name name-style="western"><surname>Brenchley</surname><given-names>J</given-names></name><name name-style="western"><surname>Sinclair</surname><given-names>E</given-names></name><name name-style="western"><surname>McCune</surname><given-names>JM</given-names></name><name name-style="western"><surname>Roland</surname><given-names>M</given-names></name><name name-style="western"><surname>Page-Shafer</surname><given-names>K</given-names></name><name name-style="western"><surname>Hsue</surname><given-names>P</given-names></name><name name-style="western"><surname>Emu</surname><given-names>B</given-names></name><name name-style="western"><surname>Krone</surname><given-names>M</given-names></name><name name-style="western"><surname>Lampiris</surname><given-names>H</given-names></name><etal/></person-group><article-title>Relationship between T cell activation and CD4&#8201;+&#8201;T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy</article-title><source>J Infect Dis</source><year>2008</year><volume>197</volume><issue>1</issue><fpage>126</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">18171295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/524143</pub-id><pub-id pub-id-type="pmcid">PMC3466592</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, Hsue P, Emu B, Krone M, Lampiris H, et al. Relationship between T cell activation and CD4&#8201;+&#8201;T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197(1):126&#8211;33.<pub-id pub-id-type="pmid">18171295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/524143</pub-id><pub-id pub-id-type="pmcid">PMC3466592</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burdo</surname><given-names>TH</given-names></name><name name-style="western"><surname>Lo</surname><given-names>J</given-names></name><name name-style="western"><surname>Abbara</surname><given-names>S</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J</given-names></name><name name-style="western"><surname>DeLelys</surname><given-names>ME</given-names></name><name name-style="western"><surname>Preffer</surname><given-names>F</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>ES</given-names></name><name name-style="western"><surname>Williams</surname><given-names>KC</given-names></name><name name-style="western"><surname>Grinspoon</surname><given-names>S</given-names></name></person-group><article-title>Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients</article-title><source>J Infect Dis</source><year>2011</year><volume>204</volume><issue>8</issue><fpage>1227</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">21917896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jir520</pub-id><pub-id pub-id-type="pmcid">PMC3203384</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011;204(8):1227&#8211;36.<pub-id pub-id-type="pmid">21917896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jir520</pub-id><pub-id pub-id-type="pmcid">PMC3203384</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ledwaba</surname><given-names>L</given-names></name><name name-style="western"><surname>Tavel</surname><given-names>JA</given-names></name><name name-style="western"><surname>Khabo</surname><given-names>P</given-names></name><name name-style="western"><surname>Maja</surname><given-names>P</given-names></name><name name-style="western"><surname>Qin</surname><given-names>J</given-names></name><name name-style="western"><surname>Sangweni</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Follmann</surname><given-names>D</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>JA</given-names></name><name name-style="western"><surname>Orsega</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>3</issue><fpage>e24243</fpage><pub-id pub-id-type="pmid">22448211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0024243</pub-id><pub-id pub-id-type="pmcid">PMC3308955</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ledwaba L, Tavel JA, Khabo P, Maja P, Qin J, Sangweni P, Liu X, Follmann D, Metcalf JA, Orsega S, et al. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease. PLoS One. 2012;7(3):e24243.<pub-id pub-id-type="pmid">22448211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0024243</pub-id><pub-id pub-id-type="pmcid">PMC3308955</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name></person-group><article-title>Acute phase reactant serum amyloid A in inflammation and other diseases</article-title><source>Adv Clin Chem</source><year>2019</year><volume>90</volume><fpage>25</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">31122611</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/bs.acc.2019.01.002</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Zhang Y, Zhang J, Sheng H, Li H, Wang R. Acute phase reactant serum amyloid A in inflammation and other diseases. Adv Clin Chem. 2019;90:25&#8211;80.<pub-id pub-id-type="pmid">31122611</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/bs.acc.2019.01.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Webb</surname><given-names>NR</given-names></name></person-group><article-title>High-density lipoproteins and Serum Amyloid A (SAA)</article-title><source>Curr Atheroscler Rep</source><year>2021</year><volume>23</volume><issue>2</issue><fpage>7</fpage><pub-id pub-id-type="pmid">33447953</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11883-020-00901-4</pub-id><pub-id pub-id-type="pmcid">PMC7808882</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Webb NR. High-density lipoproteins and Serum Amyloid A (SAA). Curr Atheroscler Rep. 2021;23(2):7.<pub-id pub-id-type="pmid">33447953</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11883-020-00901-4</pub-id><pub-id pub-id-type="pmcid">PMC7808882</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arenas-Pinto</surname><given-names>A</given-names></name><name name-style="western"><surname>Milinkovic</surname><given-names>A</given-names></name><name name-style="western"><surname>Peppa</surname><given-names>D</given-names></name><name name-style="western"><surname>McKendry</surname><given-names>A</given-names></name><name name-style="western"><surname>Maini</surname><given-names>M</given-names></name><name name-style="western"><surname>Gilson</surname><given-names>R</given-names></name></person-group><article-title>Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study</article-title><source>BMC Infect Dis</source><year>2015</year><volume>15</volume><fpage>138</fpage><pub-id pub-id-type="pmid">25888119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-015-0889-9</pub-id><pub-id pub-id-type="pmcid">PMC4374398</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Arenas-Pinto A, Milinkovic A, Peppa D, McKendry A, Maini M, Gilson R. Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study. BMC Infect Dis. 2015;15:138.<pub-id pub-id-type="pmid">25888119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-015-0889-9</pub-id><pub-id pub-id-type="pmcid">PMC4374398</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Husebekk</surname><given-names>A</given-names></name><name name-style="western"><surname>Permin</surname><given-names>H</given-names></name><name name-style="western"><surname>Husby</surname><given-names>G</given-names></name></person-group><article-title>Serum amyloid protein A (SAA): an indicator of inflammation in AIDS and AIDS-related complex (ARC)</article-title><source>Scand J Infect Dis</source><year>1986</year><volume>18</volume><issue>5</issue><fpage>389</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">3095915</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00365548609032353</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Husebekk A, Permin H, Husby G. Serum amyloid protein A (SAA): an indicator of inflammation in AIDS and AIDS-related complex (ARC). Scand J Infect Dis. 1986;18(5):389&#8211;94.<pub-id pub-id-type="pmid">3095915</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00365548609032353</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogel</surname><given-names>M</given-names></name><name name-style="western"><surname>Weissgerber</surname><given-names>P</given-names></name><name name-style="western"><surname>Goeppert</surname><given-names>B</given-names></name><name name-style="western"><surname>Hetzel</surname><given-names>J</given-names></name><name name-style="western"><surname>Vatlach</surname><given-names>M</given-names></name><name name-style="western"><surname>Claussen</surname><given-names>C</given-names></name><name name-style="western"><surname>Horger</surname><given-names>M</given-names></name></person-group><article-title>Accuracy of serum LDH elevation for the diagnosis of pneumocystis Jiroveci pneumonia</article-title><source>Swiss Med Wkly</source><year>2011</year><volume>141</volume><fpage>w13184</fpage><pub-id pub-id-type="pmid">21528464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4414/smw.2011.13184</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Vogel M, Weissgerber P, Goeppert B, Hetzel J, Vatlach M, Claussen C, Horger M. Accuracy of serum LDH elevation for the diagnosis of pneumocystis Jiroveci pneumonia. Swiss Med Wkly. 2011;141:w13184.<pub-id pub-id-type="pmid">21528464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4414/smw.2011.13184</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takata</surname><given-names>S</given-names></name><name name-style="western"><surname>Wada</surname><given-names>H</given-names></name><name name-style="western"><surname>Tamura</surname><given-names>M</given-names></name><name name-style="western"><surname>Koide</surname><given-names>T</given-names></name><name name-style="western"><surname>Higaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Mikura</surname><given-names>SI</given-names></name><name name-style="western"><surname>Yasutake</surname><given-names>T</given-names></name><name name-style="western"><surname>Hirao</surname><given-names>S</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>M</given-names></name><name name-style="western"><surname>Honda</surname><given-names>K</given-names></name><etal/></person-group><article-title>Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times</article-title><source>Biomarkers</source><year>2011</year><volume>16</volume><issue>6</issue><fpage>530</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">21854219</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/1354750X.2011.607189</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Takata S, Wada H, Tamura M, Koide T, Higaki M, Mikura SI, Yasutake T, Hirao S, Nakamura M, Honda K, et al. Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times. Biomarkers. 2011;16(6):530&#8211;5.<pub-id pub-id-type="pmid">21854219</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/1354750X.2011.607189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kokubun</surname><given-names>M</given-names></name><name name-style="western"><surname>Imafuku</surname><given-names>Y</given-names></name><name name-style="western"><surname>Okada</surname><given-names>M</given-names></name><name name-style="western"><surname>Ohguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ashikawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name></person-group><article-title>Serum Amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio</article-title><source>Clin Chim Acta</source><year>2005</year><volume>360</volume><issue>1&#8211;2</issue><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">15932751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cccn.2005.04.006</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Kokubun M, Imafuku Y, Okada M, Ohguchi Y, Ashikawa T, Yamada T, Yoshida H. Serum Amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio. Clin Chim Acta. 2005;360(1&#8211;2):97&#8211;102.<pub-id pub-id-type="pmid">15932751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cccn.2005.04.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name></person-group><article-title>Inflammatory reaction and laboratory tests: serum amyloid A (SAA) protein</article-title><source>Rinsho Byori</source><year>1990</year><volume>38</volume><issue>3</issue><fpage>249</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">2112209</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Yamada T. Inflammatory reaction and laboratory tests: serum amyloid A (SAA) protein. Rinsho Byori. 1990;38(3):249&#8211;54.<pub-id pub-id-type="pmid">2112209</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeaman</surname><given-names>MR</given-names></name></person-group><article-title>Platelets: at the nexus of antimicrobial defence</article-title><source>Nat Rev Microbiol</source><year>2014</year><volume>12</volume><issue>6</issue><fpage>426</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">24830471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrmicro3269</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Yeaman MR. Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol. 2014;12(6):426&#8211;37.<pub-id pub-id-type="pmid">24830471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrmicro3269</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nicolai</surname><given-names>L</given-names></name><name name-style="western"><surname>Gaertner</surname><given-names>F</given-names></name><name name-style="western"><surname>Massberg</surname><given-names>S</given-names></name></person-group><article-title>Platelets in host defense: experimental and clinical insights</article-title><source>Trends Immunol</source><year>2019</year><volume>40</volume><issue>10</issue><fpage>922</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">31601520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2019.08.004</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Nicolai L, Gaertner F, Massberg S. Platelets in host defense: experimental and clinical insights. Trends Immunol. 2019;40(10):922&#8211;38.<pub-id pub-id-type="pmid">31601520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2019.08.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Ahmed AS, Mahmoud MA, Gad H, Antar M, Elgazar A, Anil V, Diedrich DA, Laudanski K. Longitudinal analysis of traditional inflammatory markers (IL-6, CRP) Juxtaposed With Heparin-Binding Protein (HBP) and Serum Amyloid A Protein Component (SAA) during acute infection and convalescence from COVID-19 infection in the context of initial viral load and markers of tissue destruction. J Immunol Res. 2025;2025:8881752.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/jimr/8881752</pub-id><pub-id pub-id-type="pmcid">PMC12228567</pub-id><pub-id pub-id-type="pmid">40621180</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><name name-style="western"><surname>Cao</surname><given-names>YY</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>YD</given-names></name><name name-style="western"><surname>Yang</surname><given-names>YB</given-names></name><name name-style="western"><surname>Yan</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Akdis</surname><given-names>CA</given-names></name><name name-style="western"><surname>Gao</surname><given-names>YD</given-names></name></person-group><article-title>Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China</article-title><source>Allergy</source><year>2020</year><volume>75</volume><issue>7</issue><fpage>1730</fpage><lpage>1741</lpage><pub-id pub-id-type="pmid">32077115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/all.14238</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730&#8211;41.<pub-id pub-id-type="pmid">32077115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/all.14238</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sack</surname><given-names>GJ</given-names></name></person-group><article-title>Serum amyloid A - a review</article-title><source>Mol Med</source><year>2018</year><volume>24</volume><issue>1</issue><fpage>46</fpage><pub-id pub-id-type="pmid">30165816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s10020-018-0047-0</pub-id><pub-id pub-id-type="pmcid">PMC6117975</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Sack GJ. Serum Amyloid A - a review. Mol Med. 2018;24(1):46.<pub-id pub-id-type="pmid">30165816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s10020-018-0047-0</pub-id><pub-id pub-id-type="pmcid">PMC6117975</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>